Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomaterial‐Based In Situ Cancer Vaccines
Bo Yang, Hua Wang
Advanced Materials (2023) Vol. 36, Iss. 43
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 48
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells
Nimeet Desai, Uzma Hasan, K Jeyashree, et al.
Acta Biomaterialia (2023) Vol. 161, pp. 1-36
Open Access | Times Cited: 24
Engineered Bacteriophage-Based In Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity
Lei Lei, Jiayao Yan, Kai Xin, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12194-12209
Closed Access | Times Cited: 14
Bioorthogonal/Ultrasound Activated Oncolytic Pyroptosis Amplifies In Situ Tumor Vaccination for Boosting Antitumor Immunity
Xiaoyu Xu, Jinling Zheng, Na Liang, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9413-9430
Closed Access | Times Cited: 13
Laser‐Activatable In Situ Vaccine Enhances Cancer‐Immunity Cycle
Zhenyu Wang, Tingting You, Qianyi Su, et al.
Advanced Materials (2023) Vol. 35, Iss. 52
Closed Access | Times Cited: 18
Adoptive T cell therapy for ovarian cancer
Sarah B. Gitto, Chibuike Ihewulezi, Daniel J. Powell
Gynecologic Oncology (2024) Vol. 186, pp. 77-84
Closed Access | Times Cited: 7
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Boosting Antitumor Immunity via a Tumor Microenvironment‐Responsive Transformable Trifecta Nanovaccine
Qiang Li, Meng Dang, Junwu Tao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 26
Open Access | Times Cited: 6
Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Konstantinos Avgoustakis, Athina Angelopoulou
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 6
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 6
An In Vivo Self‐Assembled Bispecific Nanoblocker for Enhancing Tumor Immunotherapy
Xingjie Hu, Ni‐Yuan Zhang, Da‐Yong Hou, et al.
Advanced Materials (2023) Vol. 35, Iss. 45
Closed Access | Times Cited: 14
Advances in Cancer Vaccine Research
Nian Liu, Xiangyu Xiao, Zi-qiang Zhang, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 11, pp. 5999-6023
Closed Access | Times Cited: 14
Dendritic Cell-Based In Situ Nanovaccine for Reprogramming Lipid Metabolism to Boost Tumor Immunotherapy
You‐Teng Qin, Xinhua Liu, Jiaxin An, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24947-24960
Closed Access | Times Cited: 13
In Situ Self‐Aggregation of Spirulina Skeleton Fibers Enhances the Efficacy of Anti‐Tumor Thermal Immunotherapy
Yong‐Dan Qi, Ze‐Nan Zhuang, Simin Zeng, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 19
Closed Access | Times Cited: 5
Enhancing homology-directed repair efficiency with HDR-boosting modular ssDNA donor
Ying-Ying Jin, Peng Zhang, Lele Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment
Zhao Wang, Fenglin Miao, Lingwei Gu, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24219-24235
Closed Access | Times Cited: 5
Tailoring biomaterials for vaccine delivery
Yanling Zhuo, Huanxuan Zeng, Chunyu Su, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
In Silico-Guided Discovery of Polysaccharide Derivatives as Adjuvants in Nanoparticle Vaccines for Cancer Immunotherapy
Zhihong Cui, Chenyu Shi, Ran An, et al.
ACS Nano (2025)
Closed Access
Restoring Tumor Cell Immunogenicity Through Ion‐Assisted p53 mRNA Domestication for Enhanced In Situ Cancer Vaccination Effect
Yan Liang, Jingge Zhang, Jinjin Wang, et al.
Advanced Science (2025)
Open Access
An all-in-one polymeric nanomedicine as in situ cascade cancer vaccine for potent cancer immunotherapy
Bin Xu, Hengliang Hou, Weijia Xu, et al.
Nano Today (2025) Vol. 62, pp. 102691-102691
Closed Access
Engineering microcapsules with immune modulatory properties: Applications in cancer, inflammation, and autoimmunity
Xin Tan, Renwang Sheng, Liqin Ge
Chemical Engineering Journal (2025), pp. 161208-161208
Closed Access
Immunomodulatory Bioadhesive Technologies
Xiaoyi Lan, Eleanor Johnston, Tianqin Ning, et al.
Biomaterials (2025), pp. 123274-123274
Open Access
Construction of In Situ Personalized Cancer Vaccines by Bioorthogonal Catalytic Microneedles for Augmented Melanoma Immunotherapy
Qianhe Xu, Xiu‐Yuan Yin, Z. Chen, et al.
Small (2025)
Closed Access
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective
Qing-Juan Wu, Wenliang Lv
IET Nanobiotechnology (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top